UnknownPhase 1

A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP

China60 participantsStarted 2014-01

Plain-language summary

The investigators assessed the utility of ultrasonography in confirming the position of nasal jejunal tube after bedside placement when compared with endoscopic placement in patients with severe acute pancreatitis. Primary endpoint: Success rate. Secondary Endpoint: Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after placement), Tolerance of enteral nutrition, Time to approach the target calories.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * acute pancreatitis patients who need enteral nutrition; * patients in acute phase of pancreatitis (within 2 weeks from onset); * the severity of pancreatitis is equal to or above moderate (according to the revised classification of pancreatitis). Exclusion Criteria: * diagnosed with IAH(Intra-abdominal pressure) IV grade, abdominal compartment syndrome (ACS); * patients who have circulatory failure; * patients who have gastrointestinal bleeding; * patients who have specific diseases such as chronic digestive diseases and autoimmune diseases; * patients in pregnancy.

What they're measuring

Success rate

Timeframe: 24 hours

Trial details

NCT IDNCT02456155

SponsorLi Gang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-01

Contact for this trial

Gang Li, MD.

+86-025-80861655 nju8icu@126.com

View on ClinicalTrials.gov More Bedside Placement of Nasal Jejunal Tube trials